EGFR and non-small cell lung carcinoma: Furthermore, this study focused on the impact of sequential first- to third-generation EGFR-TKI treatment on top-QTc in NSCLC patients; further comparison between this subgroup of patients and those who take third-generation EGFR-TKI as initial treatment should be performed.